In DMARD-IR early nonresponders , 29.0 % , 17.2 % , and 3.7 % of TCZ 8 mg/kg-randomized , TCZ 4 mg/kg-randomized , and placebo-randomized patients , respectively , achieved 28-joint Disease Activity Score ( DAS28 ) 3.2 by Week 24 .